China vs Indonesia: New or unknown treatment history cases: Pulmonary, bacteriologically
China
326,625
in 2023
Indonesia
376,117
in 2023
China rank
3rd
Indonesia rank
2nd
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- China
- Indonesia
How they compare
Indonesia currently reports 376,117 against 326,625 in China, a difference of 49,492.
That makes Indonesia's figure about 1.2 times China's.
The two have swapped places 1 time across 11 shared years of data; in 2013 it was China ahead.
China ranks 3rd and Indonesia ranks 2nd of 197 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 241,700 | 205,135 | 36,565 | China |
| 2020s | 297,397 | 277,264 | 20,134 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, China or Indonesia?
- Indonesia, at 376,117 against 326,625 in China as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between China and Indonesia?
- 49,492, with Indonesia ahead.
- How many years of comparable data are there for China and Indonesia?
- 11 years are reported by both, from 2013 to 2023.
- How do China and Indonesia rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- China ranks 3rd and Indonesia ranks 2nd of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.